Literature DB >> 10334373

Physician substance use by medical specialty.

P H Hughes1, C L Storr, N A Brandenburg, D C Baldwin, J C Anthony, D V Sheehan.   

Abstract

Self-reported past year use of alcohol, tobacco, marijuana, cocaine, and two controlled prescription substances (opiates, benzodiazepines); and self-reported lifetime substance abuse or dependence was estimated and compared for 12 specialties among 5,426 physicians participating in an anonymous mailed survey. Logistic regression models controlled for demographic and other characteristics that might explain observed specialty differences. Emergency medicine physicians used more illicit drugs. Psychiatrists used more benzodiazepines. Comparatively, pediatricians had overall low rates of use, as did surgeons, except for tobacco smoking. Anesthesiologists had higher use only for major opiates. Self-reported substance abuse and dependence were at highest levels among psychiatrists and emergency physicians, and lowest among surgeons. With evidence from studies such as this one, a specialty can organize prevention programs to address patterns of substance use specific to that specialty, the specialty characteristics of its members, and their unique practice environments that may contribute risk of substance abuse and dependence.

Entities:  

Mesh:

Year:  1999        PMID: 10334373     DOI: 10.1300/J069v18n02_03

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  11 in total

1.  Work and mental health.

Authors:  Kay Wilhelm; Vivianne Kovess; Carmen Rios-Seidel; Adam Finch
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2004-11       Impact factor: 4.328

2.  Anesthesiologists recovering from chemical dependency: can they safely return to the operating room?

Authors:  Michael R Oreskovich; Ryan M Caldeiro
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

3.  Mandatory naltrexone treatment prevents relapse among opiate-dependent anesthesiologists returning to practice.

Authors:  Lisa J Merlo; William M Greene; Raymond Pomm
Journal:  J Addict Med       Date:  2011-12       Impact factor: 3.702

4.  Recovering substance-impaired pharmacists' views regarding occupational risks for addiction.

Authors:  Lisa J Merlo; Simone M Cummings; Linda B Cottler
Journal:  J Am Pharm Assoc (2003)       Date:  2012 Jul-Aug

5.  Burnout and Substance Use in Collegiate Athletic Trainers.

Authors:  Leslie W Oglesby; Andrew R Gallucci; Christopher J Wynveen; Kelly R Ylitalo; Nicholas F Benson
Journal:  J Athl Train       Date:  2020-07-01       Impact factor: 2.860

6.  Reasons for misuse of prescription medication among physicians undergoing monitoring by a physician health program.

Authors:  Lisa J Merlo; Supachoke Singhakant; Simone M Cummings; Linda B Cottler
Journal:  J Addict Med       Date:  2013 Sep-Oct       Impact factor: 3.702

7.  [Addictive behavior in anesthesia reanimation].

Authors:  Issam Serghini; Hicham Anass El Jalil; Sidi Mohamed Hanafi; Abdelkrim Mahmoudi
Journal:  Pan Afr Med J       Date:  2011-03-22

8.  Clinical observations and a ealthcare ailure ode and ffect nalysis to identify vulnerabilities in the security and accounting of medications in Ontario hospitals: a study protocol.

Authors:  Maaike de Vries; Mark Fan; Dorothy Tscheng; Michael Hamilton; Patricia Trbovich
Journal:  BMJ Open       Date:  2019-06-29       Impact factor: 2.692

9.  Physicians' occupational stress, depressive symptoms and work ability in relation to their working environment: a cross-sectional study of differences among medical residents with various specialties working in German hospitals.

Authors:  Monika Bernburg; Karin Vitzthum; David A Groneberg; Stefanie Mache
Journal:  BMJ Open       Date:  2016-06-15       Impact factor: 2.692

Review 10.  Smoking Prevalence among Physicians: A Systematic Review and Meta-Analysis.

Authors:  Anaïs Besson; Alice Tarpin; Valentin Flaudias; Georges Brousse; Catherine Laporte; Amanda Benson; Valentin Navel; Jean-Baptiste Bouillon-Minois; Frédéric Dutheil
Journal:  Int J Environ Res Public Health       Date:  2021-12-17       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.